课题基金 / 基金详情

Training a new generation of vaccinologists

Training a new generation of vaccinologists
培训新一代疫苗学家
批准号:
10838018
负责人:
Nadine Georges Rouphael
金额:
$9.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2024-08-31
关键词:

项目摘要

项目成果

Nadine Georges Rouphael的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a renewal application for the third cycle (years 11-15) of the established Emory Vaccinology Training Program T32 (VTP-T32) which was initiated in 2009. Emory University continues to be uniquely positioned to train a cadre of basic, translational, and clinical scientists with cutting edge, multi-disciplinary expertise in vaccinology-related research. The faculty preceptors have the breadth of expertise and mentoring experience that are critical for training a new generation of vaccinologists. All preceptors are affiliated with departments and programs at Emory, which include the Emory Schools of Medicine and Public Health, the Emory Vaccine Center and the joint Emory-Georgia Institute of Technology Biomedical Engineering (BME) Department at Emory. The preceptors have extensive training experience across varied vaccinology disciplines, including microbiology, immunology, infectious diseases, public health, pathology, pediatrics, epidemiology, behavior, global health, implementation science, and health policy. The fellows receive formal and informal education, career mentoring, and conduct mentored research. Our trainees acquire the skills and background necessary to succeed as future vaccinology leaders. Each trainee selects an in depth mentored research project with a preceptor from one of six Research Training Sections: 1) Pathogenesis & Vaccine Discovery; 2) Innate & Adaptive Immunity (immune responses to bacterial, protozoal, & viral antigens); 3) Translation & Delivery; 4) Vaccine Epidemiology & Clinical Trials; 5) Implementation Science & Health Policy; 6) Vaccine Safety (a dedicated CDC funded slot). Every trainee participates in two required comprehensive graduate level courses emphasizing different aspects of vaccinology, and the third required course in Responsible Conduct of Research (Ethics). The specific goals are: The specific aims of the Emory VTP-T32 include: 1- To continue implementing our systematic approach for identifying, recruiting and retaining superb motivated, and diverse post-doctoral trainees into the VTP-T32. 2- To provide each trainee with the best formal and informal vaccinology education, a robust mentored research project, and career mentoring. 3- To continue integrating the strong basic science, translational research, implementation science, clinical trials, and vaccine policy programs at Emory into a multi-faceted training experience, producing a synergistic whole greater than the sum of its individual parts.
期刊论文(118)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10900-020-00833-9
发表时间: 2021-03
期刊: Journal of community health
影响因子: 5.9
作者: [Mathewson K, Sundaram M, Bednarczyk RA]
通讯作者: Bednarczyk RA
DOI: 10.1097/ipc.0000000000000360
发表时间: 2016-05
期刊: Infectious diseases in clinical practice (Baltimore, Md.)
影响因子: --
作者: [Phadke VK, Jacob JT]
通讯作者: Jacob JT
Improving health outcomes for IPV-exposed women living with HIV.
改善暴露于 IPV 且感染 HIV 的女性的健康状况。
DOI: 10.1097/qai.0b013e3182a29f1b
发表时间: 2013
期刊: Journal of acquired immune deficiency syndromes (1999)
影响因子: --
作者: [Wingood,GinaM, DiClemente,RalphJ, Seth,Puja]
通讯作者: Seth,Puja
High prevalence of lipopolysaccharide mutants and R2-Pyocin susceptible variants in Pseudomonas aeruginosa populations sourced from cystic fibrosis lung infections.
源自囊性纤维化肺部感染的铜绿假单胞菌群体中脂多糖突变体和 R2-Pyocin 敏感变异体的患病率很高。
DOI: 10.1101/2023.04.26.538445
发表时间: 2023
期刊: bioRxiv : the preprint server for biology
影响因子: --
作者: [Mei,Madeline, Pheng,Preston, Kurzeja-Edwards,Detriana, Diggle,StephenP]
通讯作者: Diggle,StephenP
57
    Vaccine and Treatment Evaluation Units
    • 批准号:
      10493533
    • 项目类别:
    • 资助金额:
      $317.55万
    • 财政年份:
      2022
    • 负责人:
      Nadine Georges Rouphael
    • 依托单位:
    Vaccine and Treatment Evaluation Units
    • 批准号:
      10493530
    • 项目类别:
    • 资助金额:
      $31.89万
    • 财政年份:
      2021
    • 负责人:
      Nadine Georges Rouphael
    • 依托单位:
    Vaccine and Treatment Evaluation Units
    • 批准号:
      10493532
    • 项目类别:
    • 资助金额:
      $51.84万
    • 财政年份:
      2021
    • 负责人:
      Nadine Georges Rouphael
    • 依托单位:
    Vaccine and Treatment Evaluation Units
    • 批准号:
      10406740
    • 项目类别:
    • 资助金额:
      $469.92万
    • 财政年份:
      2021
    • 负责人:
      Nadine Georges Rouphael
    • 依托单位:
    海外基金